XCSE
EMBLA
Market cap1.93bUSD
May 03, Last price
29.50DKK
Name
Ossur hf
Chart & Performance
P/E
28.29
P/S
2.26
EPS
0.16
Div Yield, %
—
Shrs. gr., 5y
0.10%
Rev. gr., 5y
4.49%
Revenues
855m
+8.81%
Net income
68m
+16.94%
CFO
116m
+23.05%
Dividend
Mar 13, 20200.15 DKK/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Embla Medical hf is a global enterprise dedicated to the orthopaedic sector. Its primary focus involves the conceptualization, progression, manufacturing, and international distribution of non-surgical orthopaedic solutions. The company's business activities are geographically divided into three main regions: the Americas; Europe, the Middle East, and Africa (EMEA); and the Asia-Pacific territory. Established in 1971 by Össur Kristinsson, Embla Medical hf maintains its corporate headquarters in Reykjavík, Iceland.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||